Active · per the CBE, 29 October 2026

U C B

BE0403053608

Rechtspersoon Public limited company 1 establishment

U C B is registered with the CBE as active in: Managementactiviteiten van holdings. Public Limited, started on 26 May 1925, 1 establishment.

Researchdreef 60, 1070 Anderlecht

Active for

101 year, 5 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Busy address KBO

    10 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

U C B from Anderlecht, company number BE0403053608, closed financial year 2025 with a result of € 383.4 million after tax. Compared with financial year 2024, the result moved from € 389.6 million to € 383.4 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 12, 2026.

What it is worth Growing

€ 9.2 billion

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 383.4 million

▼ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 2.3 million

▼ 94% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 276.4 million paid out

72 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

207.2

▲ 15.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 77.9 million

▲ 17% vs 2024

€ 376,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1.1 million

▼ 37% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 2.8 billion

▼ 23% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 17.4 million

▼ 26% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 95 days on average.

Taxes and wages

€ 12 million

▲ 14% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Profit after taxes € 209,835,695 € 274,117,632 € 389,632,383 € 383,401,229 ▼ 2%
Equity € 8,912,700,512 € 8,927,759,376 € 9,053,357,793 € 9,160,338,136 ▲ 1%
Total debts € 4,047,570,075 € 4,115,881,042 € 4,108,517,404 € 3,296,841,396 ▼ 20%
Cash € 13,632,702 € 39,161,262 € 40,076,529 € 2,253,653 ▼ 94%
Land & buildings € 27,103,309 € 31,676,874 € 30,706,099 € 31,084,232 ▲ 1%
Retained profit € 6,329,641,876 € 6,344,700,740 € 6,470,299,157 € 6,577,279,500 ▲ 2%
Dividend € 252,318,837 € 259,058,769 € 264,033,966 € 276,420,886 ▲ 5%
Bank debt € 3,625,593,302 € 3,650,280,033 € 3,623,126,278 € 2,802,386,762 ▼ 23%
Balance sheet total € 12,985,137,144 € 13,064,527,571 € 13,205,512,692 € 12,509,165,232 ▼ 5%
Employees (FTE) 189.5 189.4 192 207.2 ▲ 15.2

Key figures of U C B, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to U C B?

What happened at U C B in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Stefaan HEYLEN stepped down as director. NBB
  • Jonathan PEACOCK stepped down as director. NBB
  • Fiona POWRIE stepped down as director. NBB
  • Ulf WIINBERG stepped down as director. NBB
  • Rodolfo SAVITZKY stepped down as director. NBB
  • Nefertiti GREENE stepped down as director. NBB
  • Dolca THOMAS stepped down as director. NBB
  • Pierre GURDJIAN stepped down as director. NBB

In short

From € 209.8 million profit in 2022 to € 383.4 million profit in 2025.

Paid € 6 million in corporate taxes since 2022.

Best year ever: 2024, with € 389.6 million profit.

Paid out € 1.1 billion in dividends to the owners in total.

Management

The stake of FINANCIERE DE TUBIZE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

U C B
UCB (Investments) LTD 100%
UCB Pharma Romania SRL 100%
UCB Trading (Shanghai) Ltd. 100%
+24

The shares are held by FINANCIERE DE TUBIZE (36.3%). It owns 100% of UCB (Investments) LTD, 100% of UCB Pharma Romania SRL, 100% of UCB Pharma SA, 100% of UCB Trading (Shanghai) Ltd., 100% of UCB Bulgaria EOOD and 100% of UCB Pharma Logistics LLC itself.

Directors

According to the 2025 annual accounts

Maëlys CASTELLA

Director

since 2023 · until 2027

Ulf WIINBERG

Director

since 2024 · until 2028

Jan BERGER

Director

since 2023 · until 2027

Jean-Christophe TELLIER

Director

since 2022 · until 2026

Rodolfo SAVITZKY

Director

since 2024 · until 2028

Kay DAVIES

Director

since 2022 · until 2026

Nefertiti GREENE

Director

since 2024 · until 2028

Cédric van RIJCKEVORSEL

Director

since 2022 · until 2026

Stefaan HEYLEN

Director

since 2025 · until 2029

Dolca THOMAS

Director

since 2024 · until 2028

Jonathan PEACOCK

Chairman of the board

since 2025 · until 2029

Pierre GURDJIAN

Director

since 2024 · until 2028

Charles-Antoine JANSSEN

Director

since 2024 · until 2028

Fiona POWRIE

Director

since 2026 · until 2029

Cyril JANSSEN

Director

since 2023 · until 2027

Shareholders

Participations

UCB (Investments) LTD

100%

UCB Pharma Romania SRL

100%

UCB Trading (Shanghai) Ltd.

100%

UCB Bulgaria EOOD

100%

UCB Pharma Logistics LLC

100%

UCB Pharma A.S. (TURKEY)

100%

UCB Pharma France SAS

100%

UCB Australia Pty. LTD

100%

UCB S.R.O.

100%

UCB DE MEXICO S.A. de C.V.

100%

UCB Japan Co LTD

100%

UCB Pharma S.A. (Spain)

100%

UCB Pharma LLC (Russia)

100%

UCB (Pharma) Ireland LTD

100%

Vedim Sp. z.o.o.

100%

UCB HUNGARY LTD

100%

UCB Pharmaceuticals (Taiwan) Ltd

100%

UCB Korea Co LTD

100%

UCB Manufacturing Ireland Ltd.

100%

UCB Biopharma S.A.

100%

UCB India Private Ltd

100%

UCB Pharma S.P.A. (Italy)

99.9%

UCB A.E. (Greece)

99.9%

UCB Pharma (Produtos Farmacêuticos) Lda

98.3%

UCB Pharma Sp. z.o.o. (Poland)

78.1%

UCB GMBH

5.2%

Establishments

Establishment units

Physical locations of this company

Registered office

Researchdreef 60

1070 Anderlecht

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 10 companies are registered at this address.

All companies at this address →

+5 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0403.053.608
VAT number
BE 0403.053.608
Registered office
Researchdreef 60, 1070 Anderlecht
Names & denominations
U C B
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
26 May 1925
Peppol
Active · Active since 24 Dec 2025
Activities · NACE

Managementactiviteiten van holdings

Activiteiten van holdings

Overige zakelijke dienstverlening, neg

Overige zakelijke dienstverlening, n.e.g.

Holdings

Vervaardiging van geneesmiddelen

Frequently asked questions

What does U C B do?
U C B is registered with the CBE as active in: Managementactiviteiten van holdings. Public Limited, started on 26 May 1925, 1 establishment.
What is the address of U C B?
The registered office of U C B is located at Researchdreef 60, 1070 Anderlecht.
Is U C B still active?
Yes. According to the CBE (29 October 2026) U C B is active, legal situation “Normale toestand”, started on 26 May 1925.
Is U C B registered on Peppol?
Yes, U C B is registered on the Peppol network with ID 0208:0403053608.
What is the enterprise number of U C B?
The enterprise number of U C B is BE0403053608.
When was U C B founded?
U C B was founded on 26 May 1925.